Modelling life beneath our feet: A new step towards realistic soil ecology at the landscape scale
Peer-Reviewed Publication
Updates every hour. Last Updated: 8-Jun-2026 06:16 ET (8-Jun-2026 10:16 GMT/UTC)
New research published in Gastroenterology highlights how culture, social environment, stress, and economic conditions influence disorders of gut–brain interaction, including irritable bowel syndrome. The review, co-authored by Professor Agata Mulak of Wroclaw Medical University as part of the Rome V Criteria update, argues that sociocultural factors play a significant role in symptom development, healthcare-seeking behavior, and treatment outcomes. The findings support a more holistic and personalized approach to gastrointestinal care.
After surgery for colon cancer, many patients face the question of whether follow-up chemotherapy is necessary to prevent a possible relapse. The decision is particularly difficult in so-called Stage II, the intermediate-risk group: Although around one in five untreated patients suffers a relapse, adjuvant chemotherapy places a significant and, in some cases, unnecessary burden on many patients. A large clinical study led by Dresden University Hospital (UKD) now provides important insights for a robust basis for decision-making. These findings were presented for the first time at this year’s annual meeting of the American Society of Clinical Oncology (ASCO) and published simultaneously in the Annals of Oncology.
Europe’s food system is under growing strain from climate change, environmental pressures, and rising levels of diet-related disease. Although the EU has set ambitious goals for a greener, healthier, and more competitive and resilient agrifood system, progress remains slow. A new perspective published in Nature Food examines this gap between ambition and reality and identifies the structural barriers holding transformations back.
The study is the first output of a new European research alliance, bringing together researchers from, among others, Aarhus University in Denmark, Wageningen University & Research in the Netherlands and the French National Research Institute for Agriculture, Food and Environment (INRAE). Drawing on contributions from 34 researchers, it takes a system-wide perspective on the agrifood system, from production to consumption.
The researchers argue that the challenge is not only a lack of knowledge or willingness to change. Many actors across the food system, like farmers, policymakers, and consumers support reform. However, they operate within “lock-ins”: self-reinforcing systems of incentives, regulations, market structures, and habits that sustain the status quo.
Five key lock-ins are highlighted. First, fragmented policymaking leads to conflicting objectives across agriculture, health, environment, and trade. Second, dietary habits are difficult to shift, as cultural norms, prices, and availability often favor less sustainable food choices. Third, market structures emphasize efficiency, scale, and low costs, discouraging long-term investments in sustainability. Fourth, environmental costs such as emissions and biodiversity loss are not reflected in food prices, limiting the competitiveness of sustainable alternatives. Finally, increasing instability from climate change to geopolitical shocks exposes the fragility of a system optimized for efficiency rather than resilience.
Importantly, the authors propose five guiding principles for change in the agrifood system: prioritizing access to affordable, healthy and sustainable food; ensuring inclusive and engaging transformation processes; provide governance to strengthen transparency and accountability; leveraging Europe’s diversity in agrifood systems; and shifting mindsets towards prioritizing common goods.
The researchers emphasize that transformation will require more than technological solutions. Coordinated policy action, new incentives, and strong leadership are essential to unlock systemic change and move Europe’s food system forward.
Today's children are absorbing screens at scales no previous generation has known, during the precise developmental windows when neural architecture is most malleable. A new Thought Leaders Invited Review in Brain Health offers a framework for understanding what that means. Michel Cuenod, Julio Licinio, and Kim Q. Do introduce the criticome: the complete ensemble of sensory, motor, social, cultural, and environmental experience integrated by the brain during critical periods from before birth through roughly age twenty-five. The synthesis grounds the term in six neurobiological mechanisms and reframes autism, schizophrenia, post-traumatic stress, and major depression as developmental rather than purely synaptic disorders.
Researchers at the University of Waterloo have developed NeuroSense, a bedside monitoring system that can detect infections in brain‑injured patients far earlier than current laboratory testing. The device continuously analyzes cerebrospinal fluid for biomarkers such as glucose, lactate and pH, as well as flow rate, allowing clinicians to identify infections or drain malfunctions in near real time. By enabling faster intervention in intensive care units, NeuroSense has the potential to save lives, reduce complications and significantly lower health‑care costs.
Researchers from The University of Osaka found that nanomicelle-mediated delivery of five mRNAs involved in angiogenesis, heart cell contraction, immune and hematopoietic stem cell recruitment, and immune response suppression promoted cardiac repair and increased overall survival in a mouse model of myocardial infarction–induced heart failure. These findings suggest that a multifactorial treatment approach effectively addresses the complex nature of heart failure and could aid new treatments in regenerative medicine for cardiovascular disease.
Researchers at Ajou University School of Medicine have successfully created the world's first pure cerebral microbleed model by targeting brain vascular collagen IV. The breakthrough uncovers how these microbleeds drive cognitive declin and found a genetic link from 836 Korean human patients.